Boehringer Ingelheim

Duties & Responsibilities Drives the US collaboration with Corporate TA’s to create a consolidated medical strategy and integrated evidence plan for pulmonary fibrosis products/indications that prioritize innovation and address meaningful gaps internally and externally. Leads the indication- or product-specific co-creation with corporate partners of the relevant Global Integrated Business Plans (IBPs) and ensures US strategic business needs are fully integrated into the global IBPs. Leads the creation of the respective US Medical Affairs Plans (MAP’s) and implements Launch Excellence tactics in Medical Affairs by driving robust TA medical dialogue with the Corporate TA stakeholders, the US Launch Lead, RWE, FBM, and Medical Excellence. Effectively drives the execution of medical tactics, key data release activities, stays abreast of paradigm shifts in clinical practice, and aligns with BI / CDMA objectives, clinical development pipeline and the evolving US healthcare...